Emerging Therapies Session 3, Video 3: Bioerodable Metallic Scaffolds

Session Summary, Emerging Therapies Session 3, Video 3

The Absorb BVS was taken off the market due to safety issues after 1-3 year outcomes; this was perhaps due to overly high expectations of this first-generation device. In this session, data on the newer bioerodable metal scaffolds were presented. Hope remains that bioresorbable devices will emerge as safe, useful devices, but this is still unproven.

Faculty Disclosure   Vendor Supporters   Program Agenda   IAGS Video Menu